首页> 外文期刊>Psychosomatics >Lamotrigine-Associated Rash and Blood Dyscrasias in a Methadone-Treatment Patient With Hepatitis C
【24h】

Lamotrigine-Associated Rash and Blood Dyscrasias in a Methadone-Treatment Patient With Hepatitis C

机译:美沙酮治疗丙型肝炎患者的拉莫三嗪相关性皮疹和血液异常

获取原文
获取原文并翻译 | 示例
           

摘要

Individuals with hepatitis C infection and those in metha-done treatment are known to have high rates of mood disorders. Lamotrigine is an anticonvulsant approved by the FDA for the treatment of bipolar disorder, particularly for bipolar depression. Rash has been reported as the most frequent adverse effect of lamotrigine, whereas blood dyscrasias have been noted rarely.1 We report the occurrence of rash, thrombocytopenia, and neutropenia associated with lamotrigine in a methadone-treatment patient with hepatitis C infection.
机译:已知患有丙型肝炎感染的人和接受甲乙酮治疗的人的情绪障碍发生率很高。拉莫三嗪是FDA批准的抗惊厥药,用于治疗躁郁症,尤其是躁郁症。据报道,皮疹是拉莫三嗪最常见的不良反应,而鲜少发现血液异常。1我们报道了在接受美沙酮治疗的丙型肝炎患者中发生了与拉莫三嗪有关的皮疹,血小板减少和中性粒细胞减少症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号